Atomic-AI
Atomic-AI
AI platform for drug discovery and development, accelerating research with advanced computational tools.
About
Atomic AI is developing RNA-centric medicines using a platform that fuses machine learning and structural biology. Their core product, the ATOM-1 foundation model, enables precise predictions of RNA 3D structure to unlock new therapeutic targets. They serve the field of drug discovery, focusing on RNA-targeted small molecules and RNA-based therapeutics.
Key facts
- Website
- atomic.ai
- Headquarters
- San Francisco, United States
- Founded
- 2022
- Employees
- 30
- Total funding
- $6.2B
- Valuation
- Private
- Business model
- B2B
- Tags
- BiotechDrug DiscoveryAI-Driven Protein DesignFoundation ModelGenerative AI
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 17 Nov 2025 | Undisclosed round | $6.2B | Jeff Bezos, Jensen Huang |
| 17 May 2023 | Undisclosed round | $35M | Playground Global |
| 26 Jan 2022 | Undisclosed round | $7M | 8VC |
Tech stack
Detected on atomic.ai and in its job posts, last scanned 22 Aug 2026. Run your own scan
- Frontend
- jQuery
- Backend
- Python
- CMS / Builders
- WordPress
- Email provider
- Google Workspace
- Hiring platform
- Greenhouse
Add first review
Frequently asked
How much funding has Atomic-AI raised?
Atomic-AI has raised a total of $6.2B in funding.
How many employees does Atomic-AI have?
Atomic-AI has approximately 30 people on record.